Quality of Life of Patients With Inflammatory Bowel Disease in Bangladesh

Quality of Life of Patients With Inflammatory Bowel Disease in Bangladesh

Introduction The importance of maintaining quality of life in managing inflammatory bowel disease (IBD) has increased in recent years. However, there is a lack of studies examining the health-related quality of life (HRQoL) of IBD patients in Bangladesh. Methodology This cross-sectional study was ca...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) Vol. 15; no. 6; p. e39929
Main Authors: Ghosh, Chanchal Kumar, Islam, Sumona, Tabassum, Nowrin, Mohiuddin, Syed Arafat, Hossain, Md Mosarrof, Sarkar, Aditi, Bari, Amit
Format: Journal Article
Language:English
Published: United States Cureus Inc 04-06-2023
Cureus
Subjects:
Age groups
Crohns disease
Data collection
Gastroenterology
Hemoglobin
Inflammatory bowel disease
Internal Medicine
Laboratories
Life expectancy
Patients
Quality of life
Questionnaires
Remission (Medicine)
Statistical analysis
Bangladesh
utility index
health-related quality of life (hrqol)
ulcerative colitis
eq-5d-5l
crohn's disease
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction The importance of maintaining quality of life in managing inflammatory bowel disease (IBD) has increased in recent years. However, there is a lack of studies examining the health-related quality of life (HRQoL) of IBD patients in Bangladesh. Methodology This cross-sectional study was carried out in the IBD clinic, Bangabandhu Sheikh Mujib Medical University (BSMMU) from 2020 to 2022. Data were collected from both ulcerative colitis (UC) and Crohn's disease (CD) patients. HRQoL was recorded on the EuroQol 5 Dimension 5 Level (EQ-5D-5L) questionnaire. Statistical analysis was done by Statistical Analysis Software (SAS, SAS Institute, Cary, NC). Results The mean age was 36.3 years. The majority of the patients were male and had low incomes. People with more monthly income, more frequent relapse, extraintestinal involvement, and moderate to severe disease had lower utility index (p = 0.01, 0.01, 0.0004, and <0.0001, respectively). Among the five individual components, only usual activity was lower in UC patients (p = 0.03); all the other components and consequently the overall utility index did not vary between UC and CD. The visual analog scale (VAS) score seemed to be comparable in UC and CD patients. Conclusion In more severe and frequently relapsing cases of IBD, the utility index representing HRQoL was found to be lower. Comparatively, the HRQoL was mostly similar between patients with UC and CD. Additionally, the mean utility score in IBD patients was higher than that observed in patients with type 2 diabetes mellitus in Bangladesh.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.39929